#66FUZKK atlas leaders 1–100
CinnaGen
Iran · Middle East
BiologicsOncology / ADC / high-potency
Manufacturing profile
Biologics
Oncology / ADC / high-potency
Country: Iran
Macro-region: Middle East
Selection basis
The company is placed in positions 1–100 as a major manufacturer, biopharmaceutical group, generics/API/CDMO leader or a significant regional manufacturing participant.
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
Representative manufacturing and QC chain
- 1Cell bank or microbial seed
- 2Upstream culture or fermentation
- 3Clarification and chromatography
- 4UF/DF, formulation and sterile filtration
- 5SEC, CE, LC-MS, ELISA, qPCR and bioassay QC
- 6Contained dispensing and high-potency handling
- 7Chemical synthesis or biologic upstream
- 8Purification and formulation
- 9HPLC/LC-MS/CE and potency analytics
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Biologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality CheckerAssay & Impurity HPLC Quality CheckerLC-MS Confirmation Quality CheckerSterility Test Membrane Filtration Quality Checker
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
Methodology